ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024
ALPHAMAB-B: DATE OF BOARD MEETING
ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024
ALPHAMAB-B: POLL RESULTS OF ANNUAL GENERAL MEETING HELD ONJUNE 12, 2024
ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - COLLABORATION WITH ARRIVENT IN RELATION TOTHE RESEARCH, DEVELOPMENT ANDCOMMERCIALIZATION OF ADC PRODUCTS
ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - RESEARCH UPDATES ON A PHASE I/II CLINICAL STUDY OF JSKN003FOR THE TREATMENT OF ADVANCED SOLID TUMORS FORPRESENTATION AT 2024 ASCO ANNUAL MEETING
ALPHAMAB-B: INSIDE INFORMATION ANNOUNCEMENT - UPDATES IN RELATION TO A PHASE III CLINICAL TRIAL OF KN046FOR THE TREATMENT OF ADVANCED PDAC
ALPHAMAB-B: Next Day Disclosure Return
ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT -FIRST PATIENT DOSED IN A PHASE I CLINICAL TRIAL OF JSKN016FOR THE TREATMENT OF ADVANCED MALIGNANT SOLID TUMORS
ALPHAMAB-B: FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ONWEDNESDAY, JUNE 12, 2024
ALPHAMAB-B: NOTICE OF ANNUAL GENERAL MEETING
ALPHAMAB-B: (1) PROPOSED GRANTING OF GENERAL MANDATES TOREPURCHASE SHARES AND TO ISSUE NEW SHARES(INCLUDING RESELL OR TRANSFER TREASURY SHARES);(2) PROPOSED RE-ELECTION OF THE RETIRING DIRECTORS;(3) PROPOSED RE-APPOINTMENT OF AUDITORS;(4) PROPOSED AMENDMENTS TO T
ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
ALPHAMAB-B: 2023 ENVIRONMENTAL, SOCIAL AND GOVERNANCE REPORT
ALPHAMAB-B: 2023 Annual Report
ALPHAMAB-B: (1) GRANT OF SHARE OPTIONS UNDER THE POST-IPO SHARE OPTION SCHEME; AND (2) GRANT OF AWARD SHARES UNDER THE RESTRICTED SHARE AWARD SCHEME
ALPHAMAB-B: VOLUNTARY ANNOUNCEMENT - UPDATES ON RESULTS OF A PHASE I CLINICAL TRIAL OF JSKN003FOR THE TREATMENT OF HER2-EXPRESSING ADVANCED SOLIDTUMORS FOR PRESENTATION AT 2024 AACR ANNUAL MEETING
ALPHAMAB-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
ALPHAMAB-B: (1) REVISION OF ANNUAL CAP FOR EXISTING CONTINUINGCONNECTED TRANSACTION; AND(2) RENEWAL OF THE MASTER TECHNICAL SERVICE AGREEMENT
No Data